Company intelligence / Profile preview

Energex Systems

Unknown/Not specified explicitly but registered in NJ, New Jersey, United Statesenergexwallsystems.com ↗

Ownership: Private
Development stage: Other

Overview

The HemoModulator System underwent a Phase 1 clinical trial for safety and efficacy in reducing viral load in HIV patients using an extracorporeal ultraviolet light device. No adverse events were reported during the initial study period. The company also marketed a pulsed radiofrequency energy medical device for non-invasive relief of chronic TMJ pain. As of the last available records, no further advanced-stage clinical results or approvals are documented and the company has ceased operations.

Therapeutic areas: RheumatologyInfectious DiseasesOther
Modalities: DeviceNon-pharmacological therapy (pulsed radio frequency energy device)Ultraviolet light-based device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Energex Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Energex Systems.

Explore the full profile